NDC 80425-0227-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0227
- Requested NDC
- 80425-0227-01
- Package NDCs from labels
- 80425-0227-1, 80425-0227-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0227-1 | Ondansetron | 10 in 1 BOTTLE, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0227 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250102_f1a0cd50-aa4f-55bc-e053-2995a90a2d3a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0227-1 | EA - Each | 80425-0227 | 6b0b97f9-0549-4145-81d9-0939a1e667a5 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | American Health Packaging | 92b96072-e8f2-4fd6-aaa0-b73fed214319 | 2026-06-01 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Hospira, Inc. | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 2026-05-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Hospira, Inc. | 6a11f61b-2318-4382-2b91-4366e4bb53fa | 2026-05-22 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | A-S Medication Solutions | b60074e5-8e77-4dc0-9244-4205e4adbaef | 2026-05-11 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | c83821ad-822e-47dc-8108-612312cf3a16 | 2026-05-04 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Sportpharm LLC | c0be25a0-e13d-4242-93dc-0b86e82aadd7 | 2026-04-24 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Civica, Inc. | 70437694-0341-4f3b-824c-06843403443f | 2026-04-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Hikma Pharmaceuticals USA Inc. | 97713356-f42b-4a67-95f6-561afa68c0c2 | 2026-04-16 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 40258e4b-5e67-46c0-8ef0-3e8bfe36ba11 | 2026-04-16 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Sportpharm LLC | 98c1413c-ff7f-4554-9e9f-289038b39ca6 | 2026-04-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | REMEDYREPACK INC. | 5cc67d95-6629-4451-9e34-2f7a60482be5 | 2026-04-10 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Hikma Pharmaceuticals USA Inc. | c29ca6df-621d-44b6-98fc-b48666573366 | 2026-04-09 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 5bacb621-1261-25d9-e053-2991aa0afa3b | 2026-04-08 | Warnings, Adverse reactions | ANDA078152 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Sportpharm LLC | b1324076-f83e-4816-9e02-6b2a689010bc | 2026-04-05 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | PAI Holdings, LLC dba PAI Pharma | 68a4d845-0c1c-4867-bfca-c0fb11dc93cd | 2026-03-31 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 4dcd1e4c-6a9c-7ac6-e063-6394a90a39bf | 2026-03-24 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | JVET PHARMACEUTICALS LLC | 95ca0d81-a0a8-441d-820e-cb6624018a15 | 2026-03-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 36592150-7e19-474c-9f96-cc8341e28b5d | 2026-03-20 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | Direct Rx | b38feff2-900a-4e0c-8260-8f090edbc0bc | 2026-03-17 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | df736abd-9cec-4e90-e053-2995a90aab5e | 2026-03-13 | Warnings, Adverse reactions | ANDA078152 312087 4AF302ESOS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.